NOAEL Studies
Cosmetic Ingredient
P,ALPHA-DIMETHYLSTYRENE NOAEL Studies
CAS: 1195-32-0
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS_DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS_DB | NOAEL | 0.6 | mg/kg bw/day | rat | oral | 90 day | Subchronic | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx | NOAEL | =0.625 | mg/kg bw/day | Rat | - | 90 days | subchronic | EFSA AFC - 2009 - OutputID 2305 - Flavouring Group Evaluation 78 (FGE.78): Consideration of Aliphatic and alicyclic and aromatic hydrocarbons evaluated by JECFA (63rd meeting) structurally related to aliphatic and aromatic hydrocarbons evaluated by EFSA in FGE.25. Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food - doi:10.2903/j.efsa.2009.931 |
| EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx | NOAEL | =0.625 | mg/kg bw/day | Rat | - | 90 days | subchronic | EFSA AFC - 2009 - OutputID 2305 - Flavouring Group Evaluation 78 (FGE.78): Consideration of Aliphatic and alicyclic and aromatic hydrocarbons evaluated by JECFA (63rd meeting) structurally related to aliphatic and aromatic hydrocarbons evaluated by EFSA in FGE.25. Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food - doi:10.2903/j.efsa.2009.931 |
| EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx | NOAEL | =60 | mg/kg bw/day | Rat | - | - | reproduction toxicity | EFSA - 2014 - OutputID 2558 - development - teratogenic - Conclusion on the peer review of the pesticide risk assessment of the active substance terpenoid blend QRD-460 - doi:10.2903/j.efsa.2014.3816 |
| EFSA_OpenFoodTox_EFSA_ReferencePoints.xlsx | NOAEL | =200 | mg/kg bw/day | Rat | oral: feed | 90 days | subchronic | EFSA FEEDAP - 2019 - OutputID 3354 - no adverse effect observed at single/highest dose - Safety and efficacy of an essential oil from Origanum vulgare ssp. hirtum (Link) Ietsw. for all animal species - doi:10.2903/j.efsa.2019.5909 |
ToxValDB_EFSA 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ToxValDB_EFSA | NOAEL | =0.625 | mg/kg bw/day | Rat | oral | subchronic; 90 days | subchronic | LONG_REF=EFSA AFC (2009). Flavouring Group Evaluation 78 (FGE.78): Consideration of Aliphatic and alicyclic and aromatic hydrocarbons evaluated by JECFA (63rd meeting) structurally related to aliphatic and aromatic hydrocarbons evaluated by EFSA in FGE.25. Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food. doi:10.2903/j.efsa.2009.931.; TITLE=Flavouring Group Evaluation 78 (FGE.78): Consideration of Aliphatic and alicyclic and aromatic hydrocarbons evaluated by JECFA (63rd meeting) structurally related to aliphatic and aromatic hydrocarbons evaluated by EFSA in FGE.25. Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food; AUTHOR=EFSA AFC; DOI=doi:10.2903/j.efsa.2009.931; STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/65201d30e4b0f0a60ddd1165; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://zenodo.org/record/5076033#.Y9fEoXbMI2z; YEAR=2009; ORIGINAL_YEAR=2009; STUDY_GROUP=EFSA_dup_-_15621540_15621541_15621542:-:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_02155b32fbef3537cfedfcae43cb3604 |
openFDA substances 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | XC8HY3OB86 | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C10H12","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"XC8HY3OB86"} |
| openFDA substances | FDA UNII substance identifier | XC8HY3OB86 | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C10H12","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"XC8HY3OB86"} |
| openFDA substances | FDA UNII substance identifier | XC8HY3OB86 | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C10H12","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"XC8HY3OB86"} |
| openFDA substances | FDA UNII substance identifier | XC8HY3OB86 | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C10H12","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"XC8HY3OB86"} |